+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Norovirus Diagnostics Market 2024: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - US, Europe, Japan - Hospitals, Commercial and Public Health Labs, POC Locations

  • PDF Icon

    Report

  • August 2024
  • Region: Europe, Japan, United States
  • VPG Market Research
  • ID: 5995521
Description Jump to:
The report presents a detailed analysis of the Norovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology are reviewed.

The report provides the 5-year test volume and sales forecasts by country for the following market segments:
  • Hospitals
  • Commercial/Private Labs
  • Physician Offices
  • Public Health Labs

Related Topics

Related Reports

2024-2028 Global Norovirus Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation - Product Image

2024-2028 Global Norovirus Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • Report
  • Global
From
2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures - Hospitals, Blood Banks, Commercial Labs, POC Locations - Product Image

2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures - Hospitals, Blood Banks, Commercial Labs, POC Locations

  • Report
  • 320 Pages
  • Global
From
Norovirus Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Norovirus Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 245 Pages
  • Global
Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country, with Market Analysis, Executive Guides and Customization - Product Image

Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country, with Market Analysis, Executive Guides and Customization

  • Report
  • 501 Pages
  • Global
From
Molecular Diagnostics for Infectious Disease By Syndrome, Plex, Place and by Country. With Analysis and Executive Guides 2024 - 2028 - Product Image

Molecular Diagnostics for Infectious Disease By Syndrome, Plex, Place and by Country. With Analysis and Executive Guides 2024 - 2028

  • Report
  • 670 Pages
  • Global
From

About the Norovirus Test Market

The Norovirus Test market is a subset of the larger Infectious Disease Testing market. Norovirus is a highly contagious virus that causes gastroenteritis, or inflammation of the stomach and intestines. It is the leading cause of foodborne illness in the United States. Norovirus tests are used to detect the presence of the virus in a patient's stool sample. These tests are used to diagnose norovirus infection and to monitor the effectiveness of treatment. Norovirus tests are available in a variety of formats, including rapid tests, enzyme immunoassays, and molecular tests. Rapid tests are the most commonly used, as they provide results in a matter of minutes. Enzyme immunoassays are more accurate, but require more time to process. Molecular tests are the most accurate, but are also the most expensive. Some companies in the Norovirus Test market include Alere, Becton Dickinson, Cepheid, DiaSorin, and Roche. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.